Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients.

Transplant international : official journal of the European Society for Organ Transplantation

Volumn 5 Suppl 1, Issue , 1992, Pages

  Harper, S J ^a   Moorhouse, J ^a   Veitch, P S ^a   Horsburgh, T ^a   Walls, J ^a   Bell, P R ^a   Donnelly, P K ^a   Feehally, J ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NIFEDIPINE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; KIDNEY CIRCULATION; KIDNEY TRANSPLANTATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; CALCIUM CHANNEL BLOCKERS; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; NIFEDIPINE; RENAL CIRCULATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 9044253049     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/tri.1992.5.s1.69     Document Type: Article

References (0)